Biofrontera (BFRI) Change in Receivables (2020 - 2025)
Biofrontera (BFRI) posted quarterly Change in Receivables of $4.3 million for Q4 2025, up 768.29% year-over-year from $492000.0 in Q4 2024, and up 551.11% quarter-over-quarter from -$947000.0 in Q3 2025.
Biofrontera (BFRI) Change in Receivables (2020 - 2025) Analysis & Trends
Biofrontera's Change in Receivables history runs 6 years deep, the most recent figure standing at $4.3 million for Q4 2025.
- In Q4 2025, Change in Receivables rose 768.29% year-over-year to $4.3 million; the TTM figure through Dec 2025 stood at $1.9 million (up 505.4% YoY), while the FY2025 annual figure was $1.9 million, up 505.4% from the prior year.
- Change in Receivables for Q4 2025 stood at $4.3 million, up from -$947000.0 in the prior quarter.
- The five-year high for Change in Receivables was $4.3 million in Q4 2025, with the low at -$3.1 million in Q2 2022.
- The 5-year median for Change in Receivables is $149500.0 (2021), against an average of $222000.0.
- The sharpest annual moves came in 2022 and 2025: Change in Receivables tumbled 30900.0% in 2022, then surged 768.29% in 2025.
- Biofrontera's Change in Receivables stood at $1.8 million in 2021, then climbed by 19.7% to $2.2 million in 2022, then tumbled by 38.93% to $1.3 million in 2023, then tumbled by 63.06% to $492000.0 in 2024, then jumped by 768.29% to $4.3 million in 2025.
- Business Quant data shows BFRI's Change in Receivables at $4.3 million in Q4 2025, -$947000.0 in Q3 2025, and -$88000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Biofrontera | 18.87 Mn | 14.16 Mn | 9.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.27 Mn |
| Dec 31, 2025 | 4.27 Mn |
| Sep 30, 2025 | -947,000.00 |
| Sep 30, 2025 | -947,000.00 |
| Jun 30, 2025 | -88,000.00 |
| Jun 30, 2025 | -88,000.00 |
| Mar 31, 2025 | -1.33 Mn |
| Mar 31, 2025 | -1.33 Mn |
| Dec 31, 2024 | 492,000.00 |
| Dec 31, 2024 | 492,000.00 |
| Sep 30, 2024 | 1.40 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -1.58 Mn |
| Mar 31, 2024 | -1.58 Mn |
| Dec 31, 2023 | 1.33 Mn |
| Dec 31, 2023 | 1.33 Mn |
| Sep 30, 2023 | 1.70 Mn |
| Sep 30, 2023 | 1.70 Mn |